查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771588

mRNA合成原料市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区、细分市场预测，2025-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

mRNA合成原料市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球mRNA合成原料市场规模预计到2030年将达到23亿美元，2025年至2030年的复合年增长率为5.78%。

推动市场成长的关键因素包括学术界和工业界对 mRNA 技术的兴趣日益浓厚、mRNA 疫苗占据主导地位、研究资金不断增加等。此外，预计 RNA 技术的治疗应用日益增加将为预测期内的 mRNA 合成原料市场提供丰厚的机会。

新冠疫情 (COVID-19) 大流行增加了对 mRNA 合成原料的需求，用于高效开发疫苗以对抗感染疾病。 mRNA 疫苗是预防新冠疫情的安全有效方法。此外，mRNA 新冠疫苗的优势激发了製药公司在全球快速使用该疫苗的兴趣。例如，美国国家过敏和感染疾病研究所 (NIAID) 和 Moderna 公司于 2020 年 3 月共同开发了 mRNA-1273（NIAID）。因此，在新冠疫情期间，mRNA 疫苗的使用量显着增加。

此外，包括诺华、Alexion、阿斯特捷利康、辉瑞、赛诺菲巴斯德和Shire在内的多家大型製药公司都已开始研发以mRNA为基础的疗法。例如，根据辉瑞与Accuitas Therapeutics于2022年1月达成的开发和选择权协议，辉瑞将有权选择将Accuitas的LNP技术授权给最多10个mRNA疗法和疫苗开发标靶。因此，製药和生物技术公司对mRNA合成原料的采用率正在不断提高，这进一步推动了市场的成长。

此外，由于mRNA转译的瞬时性以及外源物质无法整合到细胞基因组中，因此所产生的细胞治疗产品相比传统方法具有许多优势。这些优势包括易于在可接受的製造程序下生产、降低因标靶脱靶效应引起的细胞毒性、改进临床验证和监管流程等。因此，这些优势预计将增加对mRNA疗法的需求，进一步推动市场成长。

此外，基于mRNA的技术已被证明在治疗和预防多种疾病方面前景广阔。过去十年，技术和科学研究的快速发展使mRNA成为一种可行的治疗选择，解决了其应用中的许多问题，例如其半衰期短和先天免疫抗原性。例如，mRNA技术的进步可能带来更安全、更有效的方法，例如，结合新型过继性免疫疗法，可以产生尖端的嵌合体抗原受体T细胞。因此，预计mRNA技术的进步将为市场成长开闢新的途径。

然而，在研究期间，原材料的高成本可能会阻碍市场发展。例如，像 Cleancap AG 这样的原料的采购价格约占两种疫苗生产过程中总原料成本的 45%。此外，核准流程的法律规范一直是生物技术、製药和医疗技术产业最大的阻碍因素。在中国和印度等新兴国家，mRNA 合成原料市场拥有巨大的成长潜力，但由于患者群体庞大，治疗领域缺乏有效的法律规范和指导方针，预计将在未来几年阻碍市场成长。

mRNA合成原料市场报告重点

  • 根据类型，由于封端技术的进步及其在生物製药行业和研究中的应用，封端剂部分预计在预测期内以 6.42% 的最快复合年增长率增长。
  • 根据应用，疫苗製造领域在 2024 年占据全球产业主导地位，收益占有率最大。这是因为 mRNA 疫苗的生产速度比采用基于细胞培养的生产路线的传统疫苗更快，而传统疫苗往往容易失败。
  • 预计北美将在 2024 年主导全球产业，占 2023 年总收益的最大份额，超过 36.13%，并且预计在预测期内将以最高的复合年增长率增长。
  • 根据最终用途，生物製药和製药公司部门在 2023 年占据了市场主导地位，收益占有率最高，这得益于生物製药的巨大商业性成功和治疗药物需求的快速增长。

目录

第一章调查方法与范围

第二章执行摘要

第三章全球mRNA合成原料市场变数与趋势

  • 市场展望
    • 母市场展望
    • 相关/辅助市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • mRNA合成原料市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 全球mRNA合成原料市场：类型评估与趋势分析

  • 类型细分仪表板
  • 全球mRNA合成原料市场波动分析
  • 全球mRNA合成原料市场规模及趋势分析（2018-2030年）
  • 封端剂
    • CleanCap试剂（TriLink BioTechnology）
    • ARCA（防反接电容模拟）
    • 其他的
  • 核苷酸
    • 修饰核酸
    • 天然核酸
  • 质体DNA
  • 酵素
    • 聚合酵素
    • RNase抑制剂
    • DNase
  • 其他的

第五章 全球mRNA合成原料市场：应用估算及趋势分析

  • 应用程式细分仪表板
  • 全球mRNA合成原料市场使用变化分析
  • 全球mRNA合成原料市场规模及趋势分析（依应用，2018-2030年）
  • 疫苗生产
  • 药品製造
  • 其他的

第六章全球mRNA合成原料市场：最终用途估计与趋势分析

  • 最终用途细分仪表板
  • 全球mRNA合成原料市场最终用途变化分析
  • 全球mRNA合成原料市场规模及趋势分析（依最终用途，2018-2030年）
  • 生物製药和製药公司
  • CRO 和 CMO
  • 学术研究所

第七章 mRNA 合成原料市场：区域估计与趋势分析

  • 区域仪表板
  • 2018年至2030年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is estimated to reach USD 2.30 billion by 2030, registering a CAGR of 5.78% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • By type, the capping agents segment is expected to grow with the fastest CAGR of 6.42% over the forecast period, owing to the advancements in the capping technology and their applications in the biopharma industry and research.
  • By application, the vaccine production segment dominated the global industry with the largest revenue share in 2024. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2024 and accounted for the largest share of more than 36.13% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • By end-use, the biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global mRNA Synthesis Raw Materials Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. mRNA Synthesis Raw Materials Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global mRNA Synthesis Raw Materials Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Capping agents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. CleanCap Reagents (TriLink BioTechnology)
      • 4.4.2.1. CleanCap reagents (TriLink BioTechnology) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. ARCA (Anti-Reverse Cap Analog)
      • 4.4.3.1. ARCA (Anti-Reverse Cap Analog) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Nucleotides market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Modified nucleic acids
      • 4.5.2.1. Modified nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. N1-methylpseudouridine-triphosphate
        • 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
        • 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Natural nucleic acids
      • 4.5.3.1. Natural nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.2. Adenine
        • 4.5.3.2.1. Adenine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.3. Guanine
        • 4.5.3.3.1. Guanine market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.4. Cytosine
        • 4.5.3.4.1. Cytosine market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.5. Uracil
        • 4.5.3.5.1. Uracil market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Plasmid DNA market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. RNase inhibitor market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. DNase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global mRNA Synthesis Raw Materials Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global mRNA Synthesis Raw Materials Market Application Movement Analysis
  • 5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccine Production
    • 5.4.1. Vaccine production market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Therapeutics Production
    • 5.5.1. Therapeutics production market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global mRNA Synthesis Raw Materials Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global mRNA Synthesis Raw Materials Market End Use Movement Analysis
  • 6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. MRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. F. Hoffmann - La Roche Ltd.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Jena Bioscience Gmbh
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. BOC Sciences
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Maravai Lifesciences
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. New England Biolabs
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Creative Biogene
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Hongene
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 7 Global mRNA synthesis raw materials Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 18 Mexico mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Europe mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 25 UK mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 28 Germany mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 31 France mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 37 Italy mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Italy mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 40 Denmark mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 46 Sweden mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Sweden mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 56 Japan mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 Japan mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 Japan mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 59 India mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 62 South Korea mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 65 Australia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 68 Thailand mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 71 Latin America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 75 Brazil mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
  • Table 79 Argentina mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 81 MEA mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 MEA mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 MEA mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 MEA mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 85 South Africa mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 88 UAE mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 UAE mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
  • Table 92 Saudi Arabia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 mRNA synthesis raw materials market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 mRNA synthesis raw materials market: Type outlook key takeaways
  • Fig. 13 mRNA synthesis raw materials market: Type movement analysis
  • Fig. 14 Global capping agents market, 2018 - 2030 (USD Million)
  • Fig. 15 Global cleancap reagents market, 2018 - 2030 (USD Million)
  • Fig. 16 Global ARCA (anti-reverse cap analog) market, 2018 - 2030 (USD Million)
  • Fig. 17 Global others market, 2018 - 2030 (USD Million)
  • Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global modified nucleic acid market, 2018 - 2030 (USD Million)
  • Fig. 20 Global N1-methylpseudouridine-triphosphate market, 2018 - 2030 (USD Million)
  • Fig. 21 Global 5-Methylcytidine triphosphate (5mCTP) market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global natural nucleic acids market, 2018 - 2030 (USD Million)
  • Fig. 24 Global adenine market, 2018 - 2030 (USD Million)
  • Fig. 25 Global guanine market, 2018 - 2030 (USD Million)
  • Fig. 26 Global cytosine market, 2018 - 2030 (USD Million)
  • Fig. 27 Global uracil market, 2018 - 2030 (USD Million)
  • Fig. 28 Global plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 29 Global enzymes mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 30 Global polymerase market, 2018 - 2030 (USD Million)
  • Fig. 31 Global RNase inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 32 Global DNase market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Global others mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 35 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 36 mRNA synthesis raw materials market: Application movement analysis
  • Fig. 37 Global therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 38 Global vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 39 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 40 mRNA synthesis raw materials market: End-user outlook and key takeaways
  • Fig. 41 mRNA synthesis raw materials market: End-user movement analysis
  • Fig. 42 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 43 Global CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 44 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Europe mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Market scenario
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Regulatory framework
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Regulatory framework
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Regulatory framework
  • Fig. 75 Asia Pacific mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Japan mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 China mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 India mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Australia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Thailand mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 South Korea mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Brazil mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Argentina mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 MEA mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 South Africa mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Saudi Arabia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 UAE mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Kuwait mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)